Breaking News
0

Adamis Pharma (ADMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adamis Pharmaceuticals Corporation's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.70 +0.35    +8.05%
18/05 - Closed. Currency in USD ( Disclaimer )
After Hours
4.65
-0.05
-1.06%
17:26:32 - Real-time Data
Type: Equity
Market: United States
ISIN: US00547W2089 
CUSIP: 00547W208
  • Volume: 920,831
  • Bid/Ask: 4.65 / 4.75
  • Day's Range: 4.36 - 4.70
Adamis Pharmaceuticals Corporation 4.70 +0.35 +8.05%

ADMP Overview

 
Information about the Adamis Pharma Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close4.35
Day's Range4.36 - 4.7
Revenue16.26M
Open4.5
52 wk Range2.35 - 6.45
EPS - 0.59
Volume920,831
Market Cap145.24M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)794,212
P/E RatioN/A
Beta0.32
1-Year Change20.51%
Shares Outstanding33,389,410
Next Earnings DateN/A
What is your sentiment on Adamis Pharmaceuticals Corporation?
or
Market is currently closed. Voting is open during market hours.

Adamis Pharma News


Adamis Pharmaceuticals misses on revenue
Adamis Pharmaceuticals misses on revenue By Seeking Alpha - May 10, 2018

Adamis Pharmaceuticals (NASDAQ:ADMP): Q1 Net loss of $7.6MRevenue of $3.2M (+5.3% Y/Y) misses by $0.38M.Shares -1.83% AH.Press ReleaseNow read: Adamis: Wait For ItOriginal article

Adamis Pharma Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Neutral
Summary Strong Buy Strong Buy Strong Buy Strong Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 30 Current
Completed Patterns
Engulfing Bearish 15 1 May 18, 2018 03:30PM
Doji Star Bearish 1D 2 May 16, 2018
Gravestone Doji 1D 2 May 16, 2018

Adamis Pharma Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 4.70 4.65 4.75 920,831 +8.05% USD 18/05  
  Stuttgart 3.630 0.000 0.000 0 +9.01% EUR 18/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 186.31 187.81 186.13 -0.68 -0.36% 18.30M 18/05  
  Amazon.com 1,574.37 1,583.59 1,572.10 -7.39 -0.47% 2.64M 18/05  
  General Electric 14.97 15.10 14.92 -0.06 -0.40% 34.36M 18/05  
  Facebook 182.68 184.19 182.61 -1.08 -0.59% 13.13M 18/05  
  Alibaba 195.00 197.78 194.72 -1.02 -0.52% 14.24M 18/05  
  Micron 53.39 54.65 52.85 -1.31 -2.39% 46.09M 18/05  
  Lockheed Martin 320.45 322.00 319.80 +0.03 +0.01% 1.01M 18/05  
  Tencent Holdings 415.90 417.50 414.10 +4.00 +0.97% 8.16M 23:05:56  
  Baidu 253.01 264.67 251.58 -26.67 -9.54% 16.05M 18/05  
  Tesla 276.82 284.65 274.00 -7.72 -2.71% 7.25M 18/05  

Adamis Pharma Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

108

Equity Type

ORD

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADMP Comments

Write your thoughts about Adamis Pharma
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tin Tran
Tin Tran Jan 05, 2018 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone following this? What do you think of Adamis' future?
Reply
0 0
Keith Pinder
Keith Pinder Jan 05, 2018 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buyout
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email